Delivery Order 75N95022D00014-75N95022F00001

Award Date 9/22/22
Potential Completion Date 9/21/25
Potential Value $1.2M
Contracting Federal Agency
National Institute on Drug Abuse
Ultimate Awardee
Not listed
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Labor Hours
Place of Performance
MIDDLE CITY EAST, PA 19102, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
3
Legislative Mandate
Service Contract Inventory
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This contract was awarded by the Defense Health Agency to MPF Federal, LLC, a certified HUBZone, Woman-Owned, Minority-Owned Small Disadvantaged Business (SDB). The $2,500.00 firm fixed price delivery order is for military medical research and development services. MPF Federal has been awarded numerous prime federal contracts across multiple agencies to provide a diverse array of goods and services, including for the Department of Defense, Patent and Trademark Office, Environmental Protection...
This federal contract award, valued at $654,181.14, was issued by the National Center for Advancing Translational Sciences, a civilian agency under the U.S. Department of Health and Human Services. The contract was awarded to MPF Federal, LLC, a certified HUBZone, Woman-Owned, Minority-Owned Small Disadvantaged Business, to provide regulatory support for BITOX, a detoxified form of botulism neurotoxin (BONT), as a treatment for chronic neuropathic pains focusing on osteoarthritis, a degenerative...
This is a delivery order contract awarded by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), a component of the National Institutes of Health, to MPF Federal, LLC, a woman-owned small business (WOSB). The contract, valued at $5,824,263.83, is for clinical studies management and support services. MPF Federal, which is also certified as an economically disadvantaged WOSB, 8(a) Program participant, and HUBZone firm, will provide a range of professional services...
The National Institute of Child Health and Human Development (NICHD) awarded a $227,459.67 Delivery Order to MPF Federal, LLC, a certified HUBZone, Woman-Owned, Minority-Owned Small Disadvantaged Business, under the NIH Laboratory Animal Research Support (LARC IV) Indefinite Delivery Vehicle (IDV). This order is for animal care services from August 2020 through August 2021. MPF Federal has previously received numerous federal contract awards, leveraging its small business certifications to...
This is a federal contract award to MPF Federal, LLC, a certified HUBZone, Woman-Owned, Minority-Owned Small Disadvantaged Business, by the National Institute of Child Health and Human Development (NICHD), a civilian agency within the Department of Health and Human Services. The contract, valued at $211,129.20, is for animal care services and was issued as a delivery order under the NIH Laboratory Animal Research Support (LARC IV) Indefinite Delivery Vehicle (IDV). The contract does not have a...
This is a $93,567.94 definitive contract awarded by the Food and Drug Administration (FDA), a civilian agency, to MPF Federal, LLC, a woman-owned small business contractor. The contract is for strategic communication support services with a period of performance through March 12, 2019. MPF Federal, which holds several government-wide acquisition contracts, is providing a range of professional services to the FDA, including performance measurement, strategic planning, communications, program...
This is a firm fixed-price delivery order awarded by the Department of Health and Human Services' Food and Drug Administration to MPF Federal, LLC, a certified Economically Disadvantaged Women-Owned Small Business, 8(a) Program Participant, Women-Owned Small Business, and HUBZone firm. The $650,217.60 contract provides instruction, system and technology support, and organizational development services. MPF Federal, a small disadvantaged business, has been awarded multiple prime federal contracts...
The Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Child Health and Human Development (NICHD) awarded a $216,100.60 Firm Fixed Price Delivery Order contract for animal care services to MPF Federal, LLC, a certified HUBZone, Woman Owned, and Minority Owned Small Disadvantaged Business. The contract, which does not have a set-aside designation, is a Delivery Order under the NIH Laboratory Animal Research Support (LARC IV) master Indefinite...
This is a $1,815,942.64 firm fixed-price definitive contract awarded by the National Institute of Child Health and Human Development, a civilian federal agency, to MPF / Camris Solutions, LLC, a minority-owned, small disadvantaged business. The contract has a total small business set-aside designation and an ultimate completion date of September 2, 2029. The contract is for MPF/CAMRIS SOLUTIONS, LLC to provide solutions and services, though the specific products or services requested are not...
This federal contract award, valued at $3,632,884.00, was issued by the National Center for Advancing Translational Sciences (NCATS), a civilian agency, to the Lovelace Biomedical Research Institute, a not-for-profit preclinical contract research organization. The contract is for the efficacy and safety evaluation of a lead gene therapy candidate in propionic acidemia (PA) disease mouse models, as well as the development of bioanalytical assay methods. The period of performance is from September...
  • 75N95022D00014
    Indefinite Delivery Contract
  • 75N95022D00014-75N95022F00001
    Delivery Order

This is a federal contract awarded by the Department of Health and Human Services' National Institutes of Health National Center for Advancing Translational Sciences to MPF Federal, LLC, a certified HUBZone, Woman-Owned, Minority-Owned Small Disadvantaged Business. The $1,189,645.80 contract provides regulatory support for the development of lead gene therapy candidates to treat two rare genetic disorders, propionic acidemia and methylmalonic acidemia type B. The contract has a performance period that ends on September 21, 2025. MPF Federal has an existing $19 million Indefinite Delivery, Indefinite Quantity (IDIQ) contract with the National Center for Advancing Translational Sciences to provide regulatory support services. This contract award does not utilize any small business set-aside program.

Generated 5/11/24, 10:08 AM